Why an IVF Bill Is the Next Fault Line for the French Republic
By Camille Robcis,
The Washington Post
| 10. 14. 2019
Since 1994, France has banned surrogacy and restricted access to reproductive technologies to heterosexual couples who have been married or living together for more than two years, forcing single women and lesbian couples to travel to neighboring countries for fertility treatments, and gay men to resort to surrogates in countries such as the United States or the United Kingdom. On Tuesday, the French National Assembly is scheduled to vote on a bill that would finally allow access to assisted reproductive technologies, including IVF, for unmarried women and lesbian couples. Under the proposed law, the treatments would be reimbursed by Social Security, and French doctors helping these women with fertility treatments would no longer face legal sanctions. Surrogacy, however, would remain illegal.
Outside of France, the bill — and the reaction to it from the French public — has been met with bemusement. Many observers have expressed surprise that IVF access in France was restricted in the first place — and even more surprise at the furious polemic that has been unleashed in response.
After a month of fierce legislative debates...
Related Articles
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...